Trade VIR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Vir Biotechnology, Inc. (VIR) is trading at US$11.07, down 2.11% today as of Aug 28, 13:07 EDT. The company has a market capitalisation of US$1.65B. Over the past 52 weeks, VIR has traded between US$4.75 and US$11.66. On Syfe you can trade VIR with $0 commission and add it to your watchlist.
| Previous close | US$11.31 |
|---|---|
| Market cap | US$1.65B |
| 52-week range | US$4.75 – US$11.66 |
| Volume | 1.73M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Year: 2019
Vir Biotechnology Appoints Brent Sabatini as Interim Principal Financial Officer
Jul 24, 12:50 PM · MT Newswires
Vir Biotechnology Doses First Expansion Cohort Patient in Phase 1 Metastatic Prostate Cancer Trial
Apr 13, 2:04 PM · MT Newswires
Vir Biotechnology, Inc. (VIR) stock is trading at US$11.07, -2.11% from the previous close of US$11.31.
The market cap for Vir Biotechnology, Inc. (VIR) stock is approximately US$1.65B.
The 52-week high for Vir Biotechnology, Inc. (VIR) stock is US$11.66.
The 52-week low for Vir Biotechnology, Inc. (VIR) stock is US$4.75.
Vir Biotechnology, Inc. (VIR) does not currently pay a dividend.
Stay on top of VIR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
